424 related articles for article (PubMed ID: 34595734)
41. Sarm1-mediated axon degeneration requires both SAM and TIR interactions.
Gerdts J; Summers DW; Sasaki Y; DiAntonio A; Milbrandt J
J Neurosci; 2013 Aug; 33(33):13569-80. PubMed ID: 23946415
[TBL] [Abstract][Full Text] [Related]
42. Postinjury Induction of Activated ErbB2 Selectively Hyperactivates Denervated Schwann Cells and Promotes Robust Dorsal Root Axon Regeneration.
Han SB; Kim H; Lee H; Grove M; Smith GM; Son YJ
J Neurosci; 2017 Nov; 37(45):10955-10970. PubMed ID: 28982707
[TBL] [Abstract][Full Text] [Related]
43. Sarm1 Deletion, but Not Wld
Gilley J; Ribchester RR; Coleman MP
Cell Rep; 2017 Oct; 21(1):10-16. PubMed ID: 28978465
[TBL] [Abstract][Full Text] [Related]
44. Neurotoxins subvert the allosteric activation mechanism of SARM1 to induce neuronal loss.
Wu T; Zhu J; Strickland A; Ko KW; Sasaki Y; Dingwall CB; Yamada Y; Figley MD; Mao X; Neiner A; Bloom AJ; DiAntonio A; Milbrandt J
Cell Rep; 2021 Oct; 37(3):109872. PubMed ID: 34686345
[TBL] [Abstract][Full Text] [Related]
45. Primary Traumatic Axonopathy in Mice Subjected to Impact Acceleration: A Reappraisal of Pathology and Mechanisms with High-Resolution Anatomical Methods.
Ziogas NK; Koliatsos VE
J Neurosci; 2018 Apr; 38(16):4031-4047. PubMed ID: 29567804
[TBL] [Abstract][Full Text] [Related]
46. Mitochondrial dysfunction induces Sarm1-dependent cell death in sensory neurons.
Summers DW; DiAntonio A; Milbrandt J
J Neurosci; 2014 Jul; 34(28):9338-50. PubMed ID: 25009267
[TBL] [Abstract][Full Text] [Related]
47. SARM1 signaling mechanisms in the injured nervous system.
Sambashivan S; Freeman MR
Curr Opin Neurobiol; 2021 Aug; 69():247-255. PubMed ID: 34175654
[TBL] [Abstract][Full Text] [Related]
48. Sarm1 is not necessary for activation of neuron-intrinsic growth programs yet required for the Schwann cell repair response and peripheral nerve regeneration.
Schmitd LB; Hafner H; Ward A; Asghari Adib E; Biscola NP; Kohen R; Patel M; Williamson RE; Desai E; Bennett J; Saxman G; Athaiya M; Wilborn D; Shumpert J; Zhao XF; Kawaguchi R; Geschwind DH; Hoke A; Shrager P; Collins CA; Havton LA; Kalinski AL; Giger RJ
bioRxiv; 2024 Apr; ():. PubMed ID: 38496662
[TBL] [Abstract][Full Text] [Related]
49. Axon Death Pathways Converge on Axundead to Promote Functional and Structural Axon Disassembly.
Neukomm LJ; Burdett TC; Seeds AM; Hampel S; Coutinho-Budd JC; Farley JE; Wong J; Karadeniz YB; Osterloh JM; Sheehan AE; Freeman MR
Neuron; 2017 Jul; 95(1):78-91.e5. PubMed ID: 28683272
[TBL] [Abstract][Full Text] [Related]
50. NMNAT1 inhibits axon degeneration via blockade of SARM1-mediated NAD
Sasaki Y; Nakagawa T; Mao X; DiAntonio A; Milbrandt J
Elife; 2016 Oct; 5():. PubMed ID: 27735788
[TBL] [Abstract][Full Text] [Related]
51. Systemic loss of Sarm1 protects Schwann cells from chemotoxicity by delaying axon degeneration.
Tian W; Czopka T; López-Schier H
Commun Biol; 2020 Jan; 3(1):49. PubMed ID: 32001778
[TBL] [Abstract][Full Text] [Related]
52. mTORC1 Is Transiently Reactivated in Injured Nerves to Promote c-Jun Elevation and Schwann Cell Dedifferentiation.
Norrmén C; Figlia G; Pfistner P; Pereira JA; Bachofner S; Suter U
J Neurosci; 2018 May; 38(20):4811-4828. PubMed ID: 29695414
[TBL] [Abstract][Full Text] [Related]
53. SARM1-mediated wallerian degeneration: A possible mechanism underlying organophosphorus-induced delayed neuropathy.
Song M; Kang K; Song F
Med Hypotheses; 2021 Oct; 155():110666. PubMed ID: 34455132
[TBL] [Abstract][Full Text] [Related]
54. Genetic inactivation of SARM1 axon degeneration pathway improves outcome trajectory after experimental traumatic brain injury based on pathological, radiological, and functional measures.
Bradshaw DV; Knutsen AK; Korotcov A; Sullivan GM; Radomski KL; Dardzinski BJ; Zi X; McDaniel DP; Armstrong RC
Acta Neuropathol Commun; 2021 May; 9(1):89. PubMed ID: 34001261
[TBL] [Abstract][Full Text] [Related]
55. Emergence of SARM1 as a Potential Therapeutic Target for Wallerian-type Diseases.
Loring HS; Thompson PR
Cell Chem Biol; 2020 Jan; 27(1):1-13. PubMed ID: 31761689
[TBL] [Abstract][Full Text] [Related]
56. NMNAT2 supports vesicular glycolysis via NAD homeostasis to fuel fast axonal transport.
Yang S; Niou ZX; Enriquez A; LaMar J; Huang JY; Ling K; Jafar-Nejad P; Gilley J; Coleman MP; Tennessen JM; Rangaraju V; Lu HC
Mol Neurodegener; 2024 Jan; 19(1):13. PubMed ID: 38282024
[TBL] [Abstract][Full Text] [Related]
57. dSarm/Sarm1 is required for activation of an injury-induced axon death pathway.
Osterloh JM; Yang J; Rooney TM; Fox AN; Adalbert R; Powell EH; Sheehan AE; Avery MA; Hackett R; Logan MA; MacDonald JM; Ziegenfuss JS; Milde S; Hou YJ; Nathan C; Ding A; Brown RH; Conforti L; Coleman M; Tessier-Lavigne M; Züchner S; Freeman MR
Science; 2012 Jul; 337(6093):481-4. PubMed ID: 22678360
[TBL] [Abstract][Full Text] [Related]
58. Sarm1 deletion reduces axon damage, demyelination, and white matter atrophy after experimental traumatic brain injury.
Marion CM; McDaniel DP; Armstrong RC
Exp Neurol; 2019 Nov; 321():113040. PubMed ID: 31445042
[TBL] [Abstract][Full Text] [Related]
59. Gene therapy targeting SARM1 blocks pathological axon degeneration in mice.
Geisler S; Huang SX; Strickland A; Doan RA; Summers DW; Mao X; Park J; DiAntonio A; Milbrandt J
J Exp Med; 2019 Feb; 216(2):294-303. PubMed ID: 30642945
[TBL] [Abstract][Full Text] [Related]
60. Protection against oxaliplatin-induced mechanical and thermal hypersensitivity in Sarm1
Gould SA; White M; Wilbrey AL; Pór E; Coleman MP; Adalbert R
Exp Neurol; 2021 Apr; 338():113607. PubMed ID: 33460644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
